Shares of DRAM chipmaker Inotera Memories Inc (華亞科技) rocketed 9.93 percent amid speculation that its parent company, Micron Technology Inc, has become a target of China’s state-owned Tsinghua Unigroup Ltd (清華紫光) in a buyout bid worth US$23 billion.
Shares in Inotera, which is 33 percent owned by Micron, surged to NT$22.7 yesterday, with trading volume hitting a more than two-year high at 235.79 million shares.
Inotera yesterday said it does not comment on “market rumors.”
Tsinghua Unigroup, China’s largest chip design company, intends to pay US$21 a share for Micron, a 19.3 percent premium over its closing price of US$17.61 on the NASDAQ on Monday, the Wall Street Journal reported yesterday, citing an anonymous source.
The deal would be the biggest overseas acquisition by a Chinese firm if it is struck and approved by the related government agencies. Micron is the world’s third-largest DRAM chipmaker — with a market share last year of 25.1 percent — after Samsung Electronics Co and SK Hynix Co, while the company ranked No. 4 in the global NAND flash market, according to market researcher TrendForce Corp (集邦科技).
“The news will only give a short-term boost to local stocks,” said Jerry Peng (彭茂榮), a semiconductor analyst with the Industrial Technology Research Institute (工研院). “As local DRAM chipmakers still heavily rely on Micron to license advanced technologies, the deal, if it goes through, could increase uncertainty about their partnerships.”
Nanya Technology Corp (南亞科技) shares soared 8.08 percent to NT$40.8 yesterday. Nanya, which holds a 26 percent stake in Inotera, licenses 20-nanometer technology from Micron.
TrendForce said yesterday that while Tsinghua Unigroup plans to make an offer to acquire Micron, the talks are still in the preliminary stages.
The bid indicates that China has an ambition to develop its own DRAM industry. Government-led Summitview Capital (武岳峰資本) in March acquired US chip designer Integrated Silicon Solution Inc for US$640 million.
Tsinghua Unigroup’s planned bid for Micron would greatly boost China’s in-house memory manufacturing, as the US company generated US$6.72 billion, or 41.1 percent of its revenue, from China last year, Digitimes Research said in a statement yesterday.
TrendForce said it “will not be easy for Tsinghua Unigroup to clinch the deal in the short term, as it will need approval from Micron’s board of directors and its shareholders to sell the company to an overseas buyer.”
“Besides, the US government restricts exports of certain technologies that can jeopardize national security... The semiconductor industry is one of those restricted items,” TrendForce said in a separate statement.
After US chip giant Intel Corp last year invested US$1.5 billion in Tsinghua Ungroup for a 20 percent stake, a proposed Micron acquisition would allow the Chinese chip designer to obtain DRAM and NAND flash memory technologies, which would put the US government on high alert, TrendForce said.
Intel develops NAND flash memory technologies with Micron.
It would also be tough for Micron to get the Taiwanese regulator to give the deal the green light, as the semiconductor industry is a restricted investment item, Peng said.
“We have to be sure that Micron does not have a controlling interest in Inotera before giving the go-ahead to an acquisition,” an official from the Investment Commission said by telephone.
OUTBREAK: About 200 of the airline’s 1,200 pilots are not able to work. Most of them have been quarantined to prevent further infection, but 12 have COVID-19 China Airlines Ltd (CAL,中華航空) yesterday confirmed that it would temporarily reduce its cargo flight services to cope with a pilot shortage, as one-sixth of its pilots have been sidelined by a COVID-19 outbreak. “We are working out a new schedule,” the airline said in a statement after local news media reports on Saturday said that it would be reducing its cargo services from Wednesday, primarily affecting US destinations. CAL declined to give details about its new operating plan, but the reports said that it would be suspending its cargo flights to Dallas Fort Worth International Airport, Hartsfield-Jackson Atlanta International Airport and
The rise of the cryptocurrency dogecoin has reached a new level after the token was used to pay for a lunar satellite launch. SpaceX, Elon Musk’s commercial rocket firm, is to embark on a moon voyage next year carrying a so-called cubesat — a mini-satellite used for space research — from Geometric Energy Corp that has been paid for entirely in dogecoin. The development is the latest twist in the saga over the digital token, which started as a joke in 2013, but is now a dominating Internet meme and sitting on a 21,000 percent rally in the past year. Musk has
STAKING A CLAIM: Spain plans to spend about 13 billion euros to promote domestic sales of EVs, build a battery cell plant and attract automakers Spain is moving aggressively to land new battery and electric vehicle (EV) plants, using billions of EU COVID-19-pandemic relief funds to avoid being left behind as the global auto sector undertakes the biggest technology transformation in a century. As Europe’s second-largest vehicle-producing nation, behind Germany, and with the automotive sector accounting for 10 percent of its economy, Spain has a lot to lose as automakers overhaul supply chains and manufacturing for electric vehicles. Germany and No. 3 European producer France are already pouring funds into battery plants, supporting their respective national champion automakers, and Volkswagen AG and Renault SA are investing heavily
CAPACITY EXPANSION: Construction of the site, which is to be the firm’s first mRNA production facility outside of Europe, is to begin this year and likely finish in 2023 COVID-19 vaccine maker BioNTech SE yesterday said it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of messenger RNA (mRNA)-based vaccines per year. Construction of the site would start this year, and it could become operational by 2023, the German company said in a statement. “With this planned mRNA production facility, we will increase our overall network capacity, and expand our ability to manufacture and deliver our mRNA vaccines and therapies to people around the world,” BioNTech chief executive Ugur Sahin said. The vaccine produced by BioNTech jointly with Pfizer Inc of